N-Acetylmannosamine (ManNAc) | |
---|---|
Trade Name | |
Orphan Indication | GNE Myopathy (Hereditary Inclusion Body Myopathy Type 2) |
USA Market Approval | USA |
USA Designation Date | 2010-04-05 00:00:00 |
Sponsor | National Human Genome Research Institute,NIH;10 Center Drive, Bldg. 10, Room 10C-103;Bethesda, Maryland, 20892 |